MSB 1.49% 99.5¢ mesoblast limited

Analysis of the EAP, page-417

  1. 6,121 Posts.
    lightbulb Created with Sketch. 1055
    In light of COVID and associated ARDS, I wouldn't be surprised if we see Mesoblast BLA for Ryoncil considered much earlier than others in the FDA queue. I know Dr Grossman mentioned August but I think it may even be earlier. Just my sixth sense sniff sniff!!

    Below is the link to the list of BLA's with PDUFA dates. I think there are about 10 before Mesoblast.

    PDUFA dates and FDA Panel Review dates are very important because they are make or break events for biostocks when the decisions are announced. Also, usually biostocks experience a run-up going into the scheduled decision/review dates. So having prior knowledge of the catalysts goes a long way toward maximizing profit or minimizing loss while trading volatile biotech stocks.

    Listed below are large cap, mid cap and small cap stocks with pending regulatory catalysts.

    https://www.rttnews.com/CorpInfo/FDACalendar.aspx?PageNum=1

    ALSO READ - COVID-19 Drugs In Development Calendar which lists Companies that are in Race to find a Treatment or Vaccine for the Novel Coronavirus.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.5¢
Change
-0.015(1.49%)
Mkt cap ! $1.136B
Open High Low Value Volume
$1.02 $1.02 99.5¢ $2.005M 1.991M

Buyers (Bids)

No. Vol. Price($)
3 14424 99.5¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 63643 1
View Market Depth
Last trade - 16.10pm 19/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.